Dekabank Deutsche Girozentrale Reduces $6M in Enhabit Inc ($EHAB)

Key Points

  • Dekabank Deutsche Girozentrale changed its Enhabit Inc ($EHAB) stake by 100% last quarter, cutting to 0 shares.
  • Wall Street's consensus rating on $EHAB is Hold and an average price target of $13.80.
  • $EHAB last traded around $13.80.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Dekabank Deutsche Girozentrale reduced its position in Enhabit Inc ($EHAB), according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 0 shares of Enhabit Inc after selling 423,412 shares during the quarter.

Enhabit Inc Stock Up 0.1%

Shares of Enhabit Inc ($EHAB) traded around $13.80 on Saturday, up 0.1% for the day.

Last price$13.80
Market cap$706.91M
Forward P/E20.87
Beta0.96
52-week low$6.47
52-week high$14.22
50-day MA$13.76
200-day MA$10.26
Current ratio1.56
Quick ratio1.46
Debt-to-equity0.82

Enhabit Inc Earnings

EPS (ttm)-$0.07
Revenue (ttm)$1.06B
Revenue growth1.90%
Net margin-0.30%
Return on equity-0.19%

Analysts Set New Price Targets

ConsensusHold
Average target$13.80
High target$13.80
Low target$13.80
Analysts covering5

About Enhabit Inc

Enhabit, Inc. provides home health and hospice services in the United States. The Home Health segment offers nursing care; physical, occupational, and speech therapy; medical and social work; and home health aide services. This segment also provides patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care, and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery or injury, and respiratory diseases; and counseling for patients and their families regarding financial, personal, and social concerns that arise from a patient's health-related problems. Its Hospice segment offers nursing care; pain and symptom management; palliative and dietary counseling; social worker visits; spiritual counseling; and family member bereavement counseling to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is headquartered in Dallas, Texas.

ExchangeNYQ
SectorHealthcare
IndustryMedical Care Facilities
HeadquartersDallas, TX
CEOMs. Barbara Ann Jacobsmeyer B.S., M.A., P.T.
Employees10,800

Get Enhabit Inc alerts

New 13F filings, insider trades, and analyst moves on $EHAB, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.